Washington University - Siteman Cancer Center — St Louis, Missouri

Washington University - Siteman Cancer Center is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Washington University - Siteman Cancer Center has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Advanced Solid Tumor, Acute Myeloid Leukemia, Carcinoma.

Sponsors: Eikon Therapeutics, Stemline Therapeutics, Inc., NATCO Pharma Ltd..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University - Siteman Cancer Center?

Washington University - Siteman Cancer Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University - Siteman Cancer Center conducted?

Washington University - Siteman Cancer Center has 5 clinical trials on record, with 4 currently active. Their work covers Advanced Solid Tumor, Acute Myeloid Leukemia, Carcinoma.

Is Washington University - Siteman Cancer Center accredited by Crixeo Health?

Yes — Washington University - Siteman Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Washington University - Siteman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.